Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma
NCT07428148
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Oropharyngeal Squamous Cell Carcinoma
Interventions
DRUG:
Induction Chemo-Immunotherapy
RADIATION:
Lattice Radiotherapy
Sponsor
NYU Langone Health